-
This recently published Cochrane review examines the effects of a class of treatments on people with COVID-19.
Treating COVID-19 with tocilizumab (a medicine that blocks interleukin-6) reduces the numbers of people who die within 28 days of treatment, and probably results in fewer serious unwanted effects than placebo treatment.
Studies of other...
18 March 2021
-
Cochrane has signed a World Health Organization (WHO) Declaration that calls for a more equitable rollout of COVID-19 vaccines.
While several countries currently have vaccination programmes up and running, the global distribution of vaccines has so far been unequal. Many low- and middle-income countries are yet to receive any doses and...
17 March 2021
-
17 March 2021
-
Cochrane Library Special Collections provide a round-up of up-to-date Cochrane evidence on a specific topic. This Special Collection provides evidence in several key clinical priority areas for brain tumour research. The reviews in this Collection provide evidence towards clinical priority areas for research, and their funding, and therefore, are...
17 March 2021
-
Dear Colleagues,
We would like to share more information on the forthcoming virtual session on Monday 22 March 2021 (Tuesday 23 March in some timezones).
This free, online event open to everyone in Cochrane will give members the opportunity to hear updates about key organizational priorities for 2021 and beyond. So far, more than 200 people have...
16 March 2021
-
Updated Review: How accurate is chest imaging for diagnosing COVID-19?
Why is this question important?
People with suspected COVID-19 need to know quickly whether they are infected, so they can receive appropriate treatment, self-isolate, and inform close contacts.
Currently, formal diagnosis of COVID-19 requires a laboratory test (RT-PCR)...
16 March 2021
-
15 March 2021
-
15 March 2021
-
15 March 2021
-
Professor James "Jimmy" Volmink, the founding Director of the South African Cochrane Centre, was recognized for his exceptional lifelong contributions to medical research and public health with the Presidential Award from The South African Medical Research Council (SAMRC).
SAMRCed host its 7th SAMRC Scientific Merit Awards with a ceremony of a...
15 March 2021
-
11 March 2021
-
In this short interview, Prof. John GF Cleland, senior author of this recently published Cochrane review, tells us about what this review found regarding the type of heart and blood vessel problems that complicate COVID-19 infections.
Tell us about this review.
This review first focuses on cardiovascular problems pre-existing the development of...
11 March 2021
-
The annual 'Best of the Cochrane Library' Special Collection showcases Cochrane content published in various formats.
What were the most accessed Cochrane Reviews of 2020? The most accessed Cochrane Editorials or Podcasts? Find out in a Special Collection, now available on the Cochrane Library website.
Read 'Best of the Cochrane Library: 2020...
10 March 2021
-
Evidence published in the Cochrane Library today will reassure people who want to stop smoking that quitting for at least 6 weeks may improve their mental wellbeing, by reducing anxiety, depression, and stress. People’s social relationships are unlikely to suffer if they stop smoking.
Smoking is the world's leading cause of preventable illness...
9 March 2021
-
On International Women's Day 2021 we discussed and highlighted minority women and young investigators working in health science and evidence synthesis. Watch the recording to hear about their career paths, who has inspired them, and what advice they have for other women interested in or working in health evidence synthesis. Learn about Cochrane’...
9 March 2021
-
8 March 2021
-
8 March 2021
-
Supported by Cochrane Ear ,Nose and Throat a new Cochrane Library Special Collection curates the latest Cochrane evidence on non-surgical treatments for chronic suppurative otitis media (CSOM).
CSOM is estimated to have a global incidence of 31 million episodes per year, disproportionately affecting people at socio-economic disadvantage. Many...
5 March 2021
-
Cochrane is made up of 11,000 members and over 67,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.
Getting involved in Cochrane’s work means becoming part of a global...
3 March 2021
-
2 March 2021